Issue of Equity

RNS Number : 7668A

Sopheon PLC

03 June 2021

 

For immediate release

 

SOPHEON PLC

("Sopheon" or the "Company")

Issue of Equity - Option Exercise

Sopheon plc, an international global leader in enterprise innovation management solutions, announces that, following the exercise of options by a former employee, it has issued and allotted 15,415 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 10 June 2021.

The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,468,903. The Company does not hold any shares in treasury. Accordingly, the figure of 10,468,903 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information contact:

Andy Michuda (Executive Chairman) Arif Karimjee (CFO)	Sopheon plc	+ 44 (0) 1276 919 560
Carl Holmes/Edward Whiley (Corporate Finance) Alice Lane (ECM)	finnCap	+ 44 (0) 20 7220 0500

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete  enterprise innovation management  solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit  www.sopheon.com .

 

END

 

 

IOEBDGDLISGDGBX